Reyderman L - Search Results

1

Disposition of desloratadine in healthy volunteers.

Ramanathan R, Reyderman L, Su AD, Alvarez N, Chowdhury SK, Alton KB, Wirth MA, Clement RP, Statkevich P, Patrick JE. Ramanathan R, et al. Among authors: reyderman l. Xenobiotica. 2007 Jul;37(7):770-87. doi: 10.1080/00498250701463325. Xenobiotica. 2007. PMID: 17620222

2

Disposition and pharmacokinetics of temozolomide in rat.

Reyderman L, Statkevich P, Thonoor CM, Patrick J, Batra VK, Wirth M. Reyderman L, et al. Xenobiotica. 2004 May;34(5):487-500. doi: 10.1080/00498250410001685737. Xenobiotica. 2004. PMID: 15370964

3

Disposition of loratadine in healthy volunteers.

Ramanathan R, Reyderman L, Kulmatycki K, Su AD, Alvarez N, Chowdhury SK, Alton KB, Wirth MA, Clement RP, Statkevich P, Patrick JE. Ramanathan R, et al. Among authors: reyderman l. Xenobiotica. 2007 Jul;37(7):753-69. doi: 10.1080/00498250701463317. Xenobiotica. 2007. PMID: 17620221

4

Lack of clinically relevant interaction between desloratadine and erythromycin.

Banfield C, Hunt T, Reyderman L, Statkevich P, Padhi D, Affrime M. Banfield C, et al. Among authors: reyderman l. Clin Pharmacokinet. 2002;41 Suppl 1:29-35. doi: 10.2165/00003088-200241001-00005. Clin Pharmacokinet. 2002. PMID: 12169044 Clinical Trial.

5

Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers.

Reyderman L, Kosoglou T, Boutros T, Seiberling M, Statkevich P. Reyderman L, et al. Curr Med Res Opin. 2004 Sep;20(9):1493-500. doi: 10.1185/030079904X2547. Curr Med Res Opin. 2004. PMID: 15383199 Clinical Trial.

6

Validation of a sensitive and automated 96-well solid-phase extraction liquid chromatography-tandem mass spectrometry method for the determination of desloratadine and 3-hydroxydesloratadine in human plasma.

Yang L, Clement RP, Kantesaria B, Reyderman L, Beaudry F, Grandmaison C, Di Donato L, Masse R, Rudewicz PJ. Yang L, et al. Among authors: reyderman l. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 25;792(2):229-40. doi: 10.1016/s1570-0232(03)00267-8. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12860030

7

Assessment of a multiple-dose drug interaction between ezetimibe, a novel selective cholesterol absorption inhibitor and gemfibrozil.

Reyderman L, Kosoglou T, Statkevich P, Pember L, Boutros T, Maxwell SE, Affrime M, Batra V. Reyderman L, et al. Int J Clin Pharmacol Ther. 2004 Sep;42(9):512-8. doi: 10.5414/cpp42512. Int J Clin Pharmacol Ther. 2004. PMID: 15487810 Clinical Trial.

8

The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe.

Reyderman L, Kosoglou T, Cutler DL, Maxwell S, Statkevich P. Reyderman L, et al. Curr Med Res Opin. 2005 Aug;21(8):1171-9. doi: 10.1185/030079905X46386. Curr Med Res Opin. 2005. PMID: 16083526 Clinical Trial.

9

Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe.

Kosoglou T, Statkevich P, Fruchart JC, Pember LJ, Reyderman L, Cutler DL, Guillaume M, Maxwell SE, Veltri EP. Kosoglou T, et al. Among authors: reyderman l. Curr Med Res Opin. 2004 Aug;20(8):1197-207. doi: 10.1185/030079903125004277. Curr Med Res Opin. 2004. PMID: 15324522 Clinical Trial.

10

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules.

Tolcher AW, Gerson SL, Denis L, Geyer C, Hammond LA, Patnaik A, Goetz AD, Schwartz G, Edwards T, Reyderman L, Statkevich P, Cutler DL, Rowinsky EK. Tolcher AW, et al. Among authors: reyderman l. Br J Cancer. 2003 Apr 7;88(7):1004-11. doi: 10.1038/sj.bjc.6600827. Br J Cancer. 2003. PMID: 12671695 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page